New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy

Photodynamic therapy (PDT) is a cancer treatment modality that requires three components, namely light, dioxygen and a photosensitizing agent. After light excitation, the photosensitizer (PS) in its excited state transfers its energy to oxygen, which leads to photooxidation reactions. In order to improve the selectivity of the treatment, research has focused on the design of PS covalently attached to a tumor-targeting moiety. In this paper, we describe the synthesis and the physico-chemical and photophysical properties of six new peptide-conjugated photosensitizers designed for targeting the neuropilin-1 (NRP-1) receptor. We chose a TPC (5-(4-carboxyphenyl)-10,15, 20-triphenyl chlorine as photosensitizer, coupled via three different spacers (aminohexanoic acid, 1-amino-3,6-dioxaoctanoic acid, and 1-amino-9-aza-3,6,12,15-tetraoxa-10-on-heptadecanoic acid) to two different peptides (DKPPR and TKPRR). The affinity towards the NRP-1 receptor of the conjugated chlorins was evaluated along with in vitro and in vivo stability levels. The tissue concentration of the TPC-conjugates in animal model shows good distribution, especially for the DKPPR conjugates. The novel peptide–PS conjugates proposed in this study were proven to have potential to be further developed as future NRP-1 targeting photodynamic therapy agent.

[1]  A. Aubry,et al.  Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application , 2017, Journal of biomolecular structure & dynamics.

[2]  Mark E. B. Smith,et al.  Regioselective and stoichiometrically controlled conjugation of photodynamic sensitizers to a HER2 targeting antibody fragment. , 2014, Bioconjugate chemistry.

[3]  Vefa Ahsen,et al.  Monoglycoconjugated phthalocyanines: effect of sugar and linkage on photodynamic activity. , 2013, Photodiagnosis and photodynamic therapy.

[4]  Yasuyoshi Watanabe,et al.  The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents , 2013, Annals of Nuclear Medicine.

[5]  Anil K Mishra,et al.  In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects. , 2011, Journal of cancer research and therapeutics.

[6]  P. Maillard,et al.  Microwave-mediated ‘click-chemistry’ synthesis of glycoporphyrin derivatives and in vitro photocytotoxicity for application in photodynamic therapy , 2011 .

[7]  F. Guillemin,et al.  Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties. , 2010, Biochemical pharmacology.

[8]  M. Olivo,et al.  Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities , 2010, Pharmaceuticals.

[9]  Gang Zheng,et al.  Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.

[10]  F. Guillemin,et al.  Neuropilin-1 Targeting Photosensitization-Induced Early Stages of Thrombosis via Tissue Factor Release , 2010, Pharmaceutical Research.

[11]  F. Guillemin,et al.  Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo. , 2009, Journal of photochemistry and photobiology. B, Biology.

[12]  Lena Claesson-Welsh,et al.  Orf virus VEGF‐E NZ2 promotes paracellular NRP‐1/VEGFR‐2 coreceptor assembly via the peptide RPPR , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  F. Guillemin,et al.  Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[14]  C. M. Yow,et al.  Photodynamic effect in medulloblastoma: downregulation of matrix metalloproteinases and human telomerase reverse transcriptase expressions , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[15]  F. Guillemin,et al.  Metabolic Profile of a Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1: An in Vivo and in Vitro Study , 2007, Drug Metabolism and Disposition.

[16]  F. Guillemin,et al.  Recent improvements in the use of synthetic peptides for a selective photodynamic therapy. , 2006, Anti-cancer agents in medicinal chemistry.

[17]  F. Guillemin,et al.  A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  E. Marinelli,et al.  Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor* , 2006, Journal of Biological Chemistry.

[19]  Sol Kimel,et al.  Targeting small-cell lung cancer with novel fluorescent analogs of somatostatin. , 2005, Lung cancer.

[20]  F. Guillemin,et al.  Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. , 2005, Bioorganic & medicinal chemistry.

[21]  A. Engel,et al.  Influence of spacer length on the agglutination of glycolipid-incorporated liposomes by ConA as model membrane. , 2003, Journal of pharmaceutical sciences.

[22]  M. DeRosa.  Photosensitized singlet oxygen and its applications , 2002 .

[23]  R. Johnstone,et al.  Determination of Fluorescence Yields, Singlet Lifetimes and Singlet Oxygen Yields of Water‐Insoluble Porphyrins and Metalloporphyrins in Organic Solvents and in Aqueous Media , 1999 .

[24]  P. Morlière,et al.  The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. , 1991, Journal of photochemistry and photobiology. B, Biology.

[25]  M C Berenbaum,et al.  Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. , 1989, The Biochemical journal.

[26]  J. Levy,et al.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.

[27]  H. Whitlock,et al.  Diimide reduction of porphyrins , 1969 .

[28]  J. Larghero,et al.  Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. , 2012, Cellular signalling.

[29]  U. Schmidt-Erfurth,et al.  Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. , 1997, British Journal of Cancer.

[30]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.